COBISS Kooperativni online bibliografski sistem in servisi COBISS
dr. Edvin Purić [55895]
Osebna bibliografija za obdobje 2021-2026
ČLANKI IN DRUGI SESTAVNI DELI
1.01 Izvirni znanstveni članek
1.
BIAGIOTTI, Giacomo, PURIĆ, Edvin, TRICOMI, Jacopo, MRAVLJAK, Janez, CICCHI, Stefano,
LAURATI, Marco, VAN KOOYK, Yvette van, CHIODO, Fabrizio, URBANČIČ, Iztok, ANDERLUH,
Marko, RICHICHI, Barbara. A nonavalent BODIPY with a multivalent arrangement of α-mannosides
enables lectins recognition in fluorescence-based assays. RSC chemical biology. 2026, vol. , iss. , <v tisku>, ilustr. ISSN 2633-0679. https://pubs.rsc.org/en/content/articlelanding/2026/cb/d5cb00190k, DOI: 10.1039/d5cb00190k. [COBISS.SI-ID 264198147]
projekt: The financial support of this work from the Slovenian Research Agency (Grant P1-0208; P1-0060) is gratefully acknowledged. This research was supported by the Ministry of Education, Science, and Sport (MIZŠ) of the Republic of Slovenia and the European Regional Development Fund OP20.05187 RI-SI-EATRIS. We also thank Eva Cerkvenik for her assistance in the lab during FCS measurements. GB, JT, SC and BR thank (“Progetto Dipartimenti di Eccellenza 2013–2027”, allocated to the Department of Chemistry “Ugo Schiff”). B. R. thanks L’Amore di Matteo Coveri ONLUS for financial support. S. C. acknowledges the support from the European Union by the Next Generation EU project ECS00000017 ‘Ecosistema dell’Innovazione’ Tuscany Health Ecosystem (THE, PNRR, Spoke 4: Nanotechnologies for diagnosis and therapy). ML acknowledges financial support from the European Union – NextGeneration EU, DM 737/2021, “bando IR@Unifi2023”, Project code HIRES, CUP B55F21007810001, and “Progetto PNRR_CN3_RNA_Spoke_5 – PNRR_CN 3_Centro Nazionale di Ricerca Sviluppo di terapia genica e farmaci con tecnologia a RNA”, CUP B13C220010100012.
projekt: The financial support of this work from the Slovenian Research Agency (Grant P1-0208; P1-0060) is gratefully acknowledged. This research was supported by the Ministry of Education, Science, and Sport (MIZŠ) of the Republic of Slovenia and the European Regional Development Fund OP20.05187 RI-SI-EATRIS. We also thank Eva Cerkvenik for her assistance in the lab during FCS measurements. GB, JT, SC and BR thank (“Progetto Dipartimenti di Eccellenza 2013–2027”, allocated to the Department of Chemistry “Ugo Schiff”). B. R. thanks L’Amore di Matteo Coveri ONLUS for financial support. S. C. acknowledges the support from the European Union by the Next Generation EU project ECS00000017 ‘Ecosistema dell’Innovazione’ Tuscany Health Ecosystem (THE, PNRR, Spoke 4: Nanotechnologies for diagnosis and therapy). ML acknowledges financial support from the European Union – NextGeneration EU, DM 737/2021, “bando IR@Unifi2023”, Project code HIRES, CUP B55F21007810001, and “Progetto PNRR_CN3_RNA_Spoke_5 – PNRR_CN 3_Centro Nazionale di Ricerca Sviluppo di terapia genica e farmaci con tecnologia a RNA”, CUP B13C220010100012.
2.
PURIĆ, Edvin, MARINOVICH, Marina, KOJEK, Zala, KAHL-KNUTSON, Barbro, LEFFLER, Hakon,
NILSSON, Ulf, ANDERLUH, Marko, MRAVLJAK, Janez. Design, synthesis and evaluation of
a novel fluorescent probe for competitive fluorescence polarization assay to screen
galectin-8 inhibitors. Acta pharmaceutica. 2025, vol. 75, iss. 2, str. 273-282, ilustr., graf. prikazi. ISSN 1846-9558. https://acta.pharmaceutica.farmaceut.org/wp-content/uploads/2025/06/27325.pdf, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.2478/acph-2025-0010. [COBISS.SI-ID 233259779]
projekt: The financial support of this work from the European Union’s Horizon2020 program under the Marie Skłodowska-Curie grant agreement No. 765581 (project PhD4GlycoDrug; www.phd4glycodrug.eu), The Swedish Research Council (Grant no. 2020-03317) and the Slovenian Research Agency (Grants P1-0208 and J1-50026) is gratefully acknowledged. COST actions CA18103 (Innogly) and CA18132 (GLYCONanoPROBES) are also gratefully acknowledged. We thank the Consortium for Functional Glycomics, which provided a tetrasaccharide (LNnT) for a Gal-8N probe synthesis. We also thank Lund Protein Production Platform for Gal-8N expression and purification. This research was supported by the Ministry of Education, Science, and Sport (MIZŠ) of the Republic of Slovenia, the European Regional Development Fund OP20.05187 RI-SI-EATRIS, and Galecto Biotech AB.
projekt: The financial support of this work from the European Union’s Horizon2020 program under the Marie Skłodowska-Curie grant agreement No. 765581 (project PhD4GlycoDrug; www.phd4glycodrug.eu), The Swedish Research Council (Grant no. 2020-03317) and the Slovenian Research Agency (Grants P1-0208 and J1-50026) is gratefully acknowledged. COST actions CA18103 (Innogly) and CA18132 (GLYCONanoPROBES) are also gratefully acknowledged. We thank the Consortium for Functional Glycomics, which provided a tetrasaccharide (LNnT) for a Gal-8N probe synthesis. We also thank Lund Protein Production Platform for Gal-8N expression and purification. This research was supported by the Ministry of Education, Science, and Sport (MIZŠ) of the Republic of Slovenia, the European Regional Development Fund OP20.05187 RI-SI-EATRIS, and Galecto Biotech AB.
3.
PURIĆ, Edvin, HASSAN, Mujtaba, SJÖVALL, Fredrik, TOMAŠIČ, Tihomir, PEVEC, Mojca, LAH,
Jurij, ADROVER FORTEZA, Jaume, SUNDIN, Anders, LEFFLER, Hakon, NILSSON, Ulf, LOGAN,
Derek T., ANDERLUH, Marko, et al. Nanomolar inhibitor of the galectin-8 N-terminal
domain binds via a non-canonical cation-π interaction. Communications chemistry. 2025, vol. 8, [article no.] 59, 11 str., ilustr. ISSN 2399-3669. https://www.nature.com/articles/s42004-025-01458-6, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.1038/s42004-025-01458-6. [COBISS.SI-ID 229077763]
projekt: The financial support of this work from the European Union’s Horizon2020 program under the Marie Skłodowska-Curie grant agreement No. 765581 (project PhD4GlycoDrug; www.phd4glycodrug.eu), EUTOPIA PhD Co-tutelle Programme grant, The Swedish Research Council (Grant no. 2020-03317) and the Slovenian Research Agency (Grants P1-0208 and J1-50026) is gratefully acknowledged. COST actions CA18103 (Innogly) and CA18132 (GLYCONanoPROBES) are also gratefully acknowledged. We thank Consortium for Functional Glycomics, which provided a tetrasaccharide (LNnT) with a 2-azidoethyl linker for a Gal-8N probe synthesis (The synthesis of Gal-8N probe can be found in Supplementary Information). We also thank Barbro Kahl Knutson from the Department of Laboratory Medicine, Lund University for assistance with the fluorescence polarisation experiments and Lund Protein Production Platform for Gal-8N expression and purification. This research was supported by the Ministry of Education, Science, and Sport (MIZŠ) of the Republic of Slovenia and the European Regional Development Fund OP20.05187 RI-SI-EATRIS.
projekt: The financial support of this work from the European Union’s Horizon2020 program under the Marie Skłodowska-Curie grant agreement No. 765581 (project PhD4GlycoDrug; www.phd4glycodrug.eu), EUTOPIA PhD Co-tutelle Programme grant, The Swedish Research Council (Grant no. 2020-03317) and the Slovenian Research Agency (Grants P1-0208 and J1-50026) is gratefully acknowledged. COST actions CA18103 (Innogly) and CA18132 (GLYCONanoPROBES) are also gratefully acknowledged. We thank Consortium for Functional Glycomics, which provided a tetrasaccharide (LNnT) with a 2-azidoethyl linker for a Gal-8N probe synthesis (The synthesis of Gal-8N probe can be found in Supplementary Information). We also thank Barbro Kahl Knutson from the Department of Laboratory Medicine, Lund University for assistance with the fluorescence polarisation experiments and Lund Protein Production Platform for Gal-8N expression and purification. This research was supported by the Ministry of Education, Science, and Sport (MIZŠ) of the Republic of Slovenia and the European Regional Development Fund OP20.05187 RI-SI-EATRIS.
4.
BIAGIOTTI, Giacomo, PURIĆ, Edvin, URBANČIČ, Iztok, KRIŠELJ, Ana, WEISS, Matjaž, MRAVLJAK,
Janez, GELLINI, Cristina, LAY, Luigi, CHIODO, Fabrizio, ANDERLUH, Marko, et al. Combining
cross-coupling reaction and Knoevenagel condensation in the synthesis of glyco-BODIPY
probes for DC-SIGN super-resolution bioimaging. Bioorganic chemistry. 2021, vol. 109, str. 1-10, ilustr. ISSN 0045-2068. https://www.sciencedirect.com/science/article/pii/S0045206821001073?casa_token=HzJ-g6Cn8OUAAAAA:eD-hnCXf40Xf_YPGVDoy1051o5Pc2BOdP8Le6m5lXQ5CROwhvZXT0c-UiHe-5Gf7z60lVhJ6cNEa, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.1016/j.bioorg.2021.104730. [COBISS.SI-ID 52587523]
projekt: P1-0208; financer: ARRS
projekt: P1-0060; financer: ARRS
projekt: P1-0208; financer: ARRS
projekt: P1-0060; financer: ARRS
1.02 Pregledni znanstveni članek
5.
PURIĆ, Edvin, NILSSON, Ulf, ANDERLUH, Marko. Galectin-8 inhibition and functions in
immune response and tumor biology. Medicinal research reviews. 2024, vol. 44, iss. 5, str. 2236-2265, ilustr. ISSN 1098-1128. https://onlinelibrary.wiley.com/doi/10.1002/med.22041, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.1002/med.22041. [COBISS.SI-ID 192485379]
projekt: The financial support of this work from the European Union's Horizon2020 program under the Marie Skłodowska-Curie grant agreement no. 765581 (project PhD4GlycoDrug; www.phd4glycodrug.eu) and the Slovenian Research Agency (grant P1-0208) is gratefully acknowledged. COST actions CA18103 (Innogly) and CA18132 (GLYCONanoPROBES) are also gratefully acknowledged.
projekt: The financial support of this work from the European Union's Horizon2020 program under the Marie Skłodowska-Curie grant agreement no. 765581 (project PhD4GlycoDrug; www.phd4glycodrug.eu) and the Slovenian Research Agency (grant P1-0208) is gratefully acknowledged. COST actions CA18103 (Innogly) and CA18132 (GLYCONanoPROBES) are also gratefully acknowledged.
1.04 Strokovni članek
6.
PURIĆ, Edvin. Vnos cepiva v telo pomaga telesu ustvariti zaščito pred boleznijo. Vita : strokovna zdravstvenovzgojna revija. [Tiskana izd.]. sep. 2021, letn. 28, št. 93, str. 3-5. ISSN 1318-6620. https://www.revija-vita.com/vita/93/Vnos_cepiva_v_telo_pomaga_telesu_ustvariti_za%C5%A1%C4%8Dito_pred_boleznijo. [COBISS.SI-ID 84061955]
1.10 Objavljeni povzetek znanstvenega prispevka na konferenci (vabljeno predavanje)
7.
PURIĆ, Edvin, TOMAŠIČ, Tihomir, PEVEC, Mojca, LAH, Jurij, LEFFLER, Hakon, SUNDIN,
Anders, NILSSON, Ulf, LOGAN, Derek T., ANDERLUH, Marko. Nanomolar inhibitor of the
galectin-8 N-terminal domain binds via a non-canonical cation-π interaction. V: JAKOPIN,
Žiga (ur.), TOMAŠIČ, Tihomir (ur.). Crossing the Boundaries of Medicinal Chemistry : book of abstracts : Ljubljana, 25th
September 2025. Ljubljana: Faculty of Pharmacy, 2025. Str. 12. ISBN 978-961-7231-07-6. [COBISS.SI-ID
252184323]
8.
ANDERLUH, Marko, PURIĆ, Edvin, PIRKMAJER, Sergej, SMRDEL, Lara, GOBEC, Martina. Classical
inhibitors vs. PROTACs targeting galectin-8 : oral lecture. V: EUROCARB : book of abstracts. [S. l.: s. n., 2025]. Str. 173, ol129, ilustr. https://www.eurocarb2025.com/wp-content/uploads/2025/07/EUROCARB22-Book-of-ABSTRACTS.pdf. [COBISS.SI-ID 269839363]
projekt: The European Union’s Horizon2020 program No. 765581 (project PhD4GlycoDrug; www.phd4glycodrug.eu), the Slovenian Research Agency (Grants P1-0208) and COST actions CA18103 and CA18132 are gratefully acknowledged.
projekt: The European Union’s Horizon2020 program No. 765581 (project PhD4GlycoDrug; www.phd4glycodrug.eu), the Slovenian Research Agency (Grants P1-0208) and COST actions CA18103 and CA18132 are gratefully acknowledged.
9.
ANDERLUH, Marko, PURIĆ, Edvin, HASSAN, Mujtaba, SJÖVALL, Fredrik, TOMAŠIČ, Tihomir,
PEVEC, Mojca, LAH, Jurij, ADROVER FORTEZA, Jaume, LOGAN, Derek T., NILSSON, Ulf. The
road to potent galectin-8 inhibitors : lesson from benzimidazole-D-galactosides :
[presentation]. V: PACIFICHEM 2025. [S. l.: 2025]. Str. [1], ilustr. https://pacifichem.org/scientific-program/oral-presentation-schedule/. [COBISS.SI-ID 266810371]
10.
ANDERLUH, Marko, PURIĆ, Edvin, HASSAN, Mujtaba, VAN KLAVEREN, Sjors, JAKOPIN, Žiga,
TOMAŠIČ, Tihomir, NILSSON, Ulf. First-in-class selective nanomolar inhibitors of galectin-8
Nterminal domain : oral lecture. V: EUROCARB : abstract book. [S. l.: s. n., 2023]. Str. ol61, ilustr. https://www.eurocarb2023.com/eurocarb-program-abstracts/. [COBISS.SI-ID 160849411]
1.12 Objavljeni povzetek znanstvenega prispevka na konferenci
11.
PURIĆ, Edvin. Načrtovanje, sinteza in vrednotenje novih zaviralcev in himernih razgrajevalcev
človeškega galektina-8 = Design, synthesis, and evaluation of novel inhibitors and
proteolysis-targeting chimeras for human galectin-8. V: PLEVNIK, Miha (ur.). 56. Krkine nagrade : 36. simpozij : zbornik povzetkov = 56th Krka prizes : 36th Symposium
: book of abstracts : [Novo mesto, 16. oktober 2026]. Novo mesto: Krka, 2026. Str. 86. https://www.krkinenagrade.si/o-krkinih-nagradah/krkine-nagrade-po-letih/2026/. [COBISS.SI-ID 301799427]
nagrada: Krkina nagrada
nagrada: Krkina nagrada
12.
PURIĆ, Edvin, SMRDEL, Lara, MIŠ, Katarina, PIRKMAJER, Sergej, GOBEC, Martina, ANDERLUH,
Marko. Targeted degradation of galectin-8 using PROTAC technology. V: Book of abstracts : 5–9 July 2026, Bratislava, Slovakia. 32nd International Carbohydrate Symposium 2026, 5–9 July 2026, Bratislava, Slovakia.
[S. l.: s. n.], 2026. Str. 451, pp131. ISBN 978-80-975390-0-9. https://guarant.eu/ics2026/files/ics-2026-book-of-abstracts.pdf. [COBISS.SI-ID 285515523]
13.
PURIĆ, Edvin, SMRDEL, Lara, MIŠ, Katarina, PIRKMAJER, Sergej, NILSSON, Ulf, GOBEC,
Martina, ANDERLUH, Marko. Galectin-8 : moving from inhibition toward targeted protein
degradation. V: ICBTM 2026 : a hub of knowledge, skills and opportunities : Debrecen, Hungary, 25-27
June 2026 : program and abstracts. 5th International Conference on Integrative Chemistry, Biology & Translational Medicine,
Debrecen, Hungary, 25-27 June 2026. Debrecen: [s. n.], 2026. Str. 69, p7. https://e-konferencia.unideb.hu/sites/default/files/inline-files/Program%20and%20Abstracts-ICBTM-2026-k%C3%A9sz.pdf. [COBISS.SI-ID 289669891]
14.
ANDERLUH, Marko, PURIĆ, Edvin, PIRKMAJER, Sergej, SMRDEL, Lara, GOBEC, Martina, LEFFLER,
Hakon, NILSSON, Ulf. Galectin-8-targeting probes : small-molecule inhibitors versus
PROTACs versus multivalent systems : [keynote lecture]. V: ICBTM 2026 : a hub of knowledge, skills and opportunities : Debrecen, Hungary, 25-27
June 2026 : program and abstracts. 5th International Conference on Integrative Chemistry, Biology & Translational Medicine,
Debrecen, Hungary, 25-27 June 2026. Debrecen: [s. n.], 2026. Str. 15, kl7. https://e-konferencia.unideb.hu/sites/default/files/inline-files/Program%20and%20Abstracts-ICBTM-2026-k%C3%A9sz.pdf. [COBISS.SI-ID 289669379]
15.
PURIĆ, Edvin, TOMAŠIČ, Tihomir, PEVEC, Mojca, LAH, Jurij, LEFFLER, Hakon, SUNDIN,
Anders, NILSSON, Ulf, LOGAN, Derek T., ANDERLUH, Marko. Nanomolar inhibitor of the
galectin-8 n-terminal domain binds via a non-canonical cation-π interaction. V: EUROCARB : book of abstracts. [S. l.: s. n., 2025]. Str. 360, p109, ilustr. https://www.eurocarb2025.com/wp-content/uploads/2025/07/EUROCARB22-Book-of-ABSTRACTS.pdf. [COBISS.SI-ID 269841155]
projekt: The European Union’s Horizon2020 program No. 765581 (project PhD4GlycoDrug; www.phd4glycodrug.eu), The Swedish Research Council (Grant no. 2020-03317), the Slovenian Research Agency (Grants P1-0208 and J1-50026) and COST actions CA18103 and CA18132 are gratefully acknowledged
projekt: The European Union’s Horizon2020 program No. 765581 (project PhD4GlycoDrug; www.phd4glycodrug.eu), The Swedish Research Council (Grant no. 2020-03317), the Slovenian Research Agency (Grants P1-0208 and J1-50026) and COST actions CA18103 and CA18132 are gratefully acknowledged
16.
PURIĆ, Edvin, SJÖVALL, Fredrik, TOMAŠIČ, Tihomir, PEVEC, Mojca, LAH, Jurij, LOGAN,
Derek T., NILSSON, Ulf, ANDERLUH, Marko. First-in-class nanomolar inhibitors of galectin-8
N-terminal domain. V: Book of abstracts : EFMC ISMC : International Symposium on Medicinal Chemistry, Rome,
Italy, September 1-5, 2024. [S. l.: s. n.], 2024. Str. 150, p372/fp55, ilustr. https://www.efmc-ismc.org/v2/data/1725266112EFMC-ISMC-2024-BoA-web-FINAL.pdf. [COBISS.SI-ID 206801155]
17.
PURIĆ, Edvin, SJÖVALL, Fredrik, TOMAŠIČ, Tihomir, PEVEC, Mojca, LAH, Jurij, LOGAN,
Derek T., NILSSON, Ulf, ANDERLUH, Marko. First-in-class nanomolar inhibitors of galectin-8
N-terminal domain. V: Book of abstracts : EFMC ISMC : International Symposium on Medicinal Chemistry, Rome,
Italy, September 1-5, 2024. [S. l.: s. n.], 2024. Str. 363, p372/fp55, ilustr. https://www.efmc-ismc.org/v2/data/1725266112EFMC-ISMC-2024-BoA-web-FINAL.pdf. [COBISS.SI-ID 206854915]
18.
PURIĆ, Edvin, TOPLAK, Žan, HASSAN, Mujtaba, TOMAŠIČ, Tihomir, NILSSON, Ulf, ANDERLUH,
Marko. First-in-class nanomolar inhibitors of galectin-8 N-terminal domain. V: KRAJNC,
Alen (ur.), GOBEC, Martina (ur.). Brunching with soft- and research skills at UL FFA: unlocking your full potential
: 1st UL FFA Graduate Student Research Symposium : book of abstracts : University
of Ljubljana, Faculty of Pharmacy, April 2024. Online ed. Ljubljana: Faculty of Pharmacy, 2024. Str. 33, ilustr. ISBN 978-961-6378-97-0.
https://www.ffa.uni-lj.si/docs/default-source/e-knjige/brunching-with-soft-and-research-skills-at-ul-ffa.pdf?sfvrsn=2. [COBISS.SI-ID 198149635]
19.
PURIĆ, Edvin, TOPLAK, Žan, TOMAŠIČ, Tihomir, HASSAN, Mujtaba, NILSSON, Ulf, ANDERLUH,
Marko. 2-substituted galactosides as selective and potent galectin-8 ligands. V: Book of abstracts. [S. l.]: [s. n.], 2022. Str. 322, p426. https://www.efmc-ismc.org/v2/data/1661849465EFMC-ISMC-Book-Web-HD3.pdf. [COBISS.SI-ID 121127171]
MONOGRAFIJE IN DRUGA ZAKLJUČENA DELA
2.08 Doktorska disertacija
20.
PURIĆ, Edvin. Design, synthesis and evaluation of novel inhibitors and proteolysis-targeting chimeras
for human galectin-8 = Načrtovanje, sinteza in vrednotenje novih zaviralcev in himernih
razgrajevalcev človeškega galektina-8 : doktorska disertacija. Ljubljana: [E. Purić], 2025. 1 spletni vir (1 datoteka PDF ( 206 str.)), ilustr.,
graf. prikazi. https://repozitorij.uni-lj.si/IzpisGradiva.php?id=174389. [COBISS.SI-ID 252007171]
21.
PURIĆ, Edvin. Načrtovanje, sinteza in vrednotenje novih zaviralcev in himernih razgrajevalcev človeškega
galektina-8 = Design, synthesis and evaluation of novel inhibitors and proteolysis-targeting
chimeras for human galectin-8 : doktorska disertacija : raziskovalni podatki, obravnavani
v doktorskem delu : research data underlying the doctoral dissertation. Ljubljana: [E. Purić], 2025. 1 spletni vir (1 datoteka PDF (razl. pag.)). https://repozitorij.uni-lj.si/IzpisGradiva.php?id=171959. [COBISS.SI-ID 248170499]
2.09 Magistrsko delo
22.
PURIĆ, Edvin. Spremljanje internalizacije fluorescentno označene ▫$\alfa$▫ -D-manozilirane sonde v dendritične celice s superločljivostnim slikanjem. Ljubljana: [E. Purić], 2021. IX, 61 str., tabele, ilustr. [COBISS.SI-ID 75738883]
2.25 Druge monografije in druga zaključena dela
23.
PURIĆ, Edvin. Spremljanje internalizacije fluorescentno označene ▫$\alfa$▫ -D-manozilirane sonde v dendritične celice s superločljivostnim slikanjem. Ljubljana: [E. Purić], 2021. VII, 61 f., ilustr., tabele. [COBISS.SI-ID 174532099]
IZVEDENA DELA (DOGODKI)
3.15 Prispevek na konferenci brez natisa
24.
PURIĆ, Edvin. 2-substituted galactosides as selective and potent galectin-8 ligands : flash presentation
na konferenci International Meeting of Young Researchers INNOGLY & GLYCOnanoPROBESm
21st of April, 2023. [COBISS.SI-ID 269843971]
SEKUNDARNO AVTORSTVO
Somentor pri magistrskih delih (bolonjski študij)
25.
KOJEK, Zala. Sinteza in vrednotenje nove fluorescenčne sonde za test fluorescenčne polarizacije
za rešetanje zaviralcev galektina-8 = Synthesis and evaluation of a novel fluorescent
probe for a fluorescence polarization assay for screening galectin-8 inhibitors. Ljubljana: [Z. Kojek], 2026. 1 spletni vir (1 datoteka PDF (XI, 61 str.)), ilustr.,
graf. prikazi, tabele. https://repozitorij.uni-lj.si/Dokument.php?id=250425, Repozitorij Univerze v Ljubljani – RUL. [COBISS.SI-ID 300977155]